Project #14:
How has the COVID-19 pandemic impacted the number of PSA tests performed to diagnose/monitor prostate cancer?

The NHS Cancer Programme is working to identify more people with prostate cancer as part of the pandemic recovery. To aid that work, we would like to know:

• What was the impact of the pandemic on the number of patients who received prostate-specific antigen (PSA) tests?
• If there was an impact on PSA test undertaken, which patients did this affect (by patient characteristic, geography, symptoms at presentation)?
• Was the change in the quantity of PSA tests undertaken followed by a corresponding drop in the number of patients receiving onwards tests and treatment for prostate cancer?